ArticleThe Journal of clinical investigation2019

Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington's disease.

Elena Vezzoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.